Cybin Inc. (CYBN) — Cybin initiated an at-the-market equity program allowing it to sell up to US$100 million of common shares from treasury at prevailing prices, managed by Cantor Fitzgerald and established via a prospectus supplement dated December 30, 2025.
The program gives the company flexible access to capital to fund its late-stage CYB003 and CYB004 programs just ahead of its Nasdaq listing transition and Helus Pharma rebrand; some coverage noted the stock dipped on the dilution potential.
Source: businesswire.com
For the rest of that week's sector news, read our week in review.